Elmelech Idaninsider trades
In SEC Form 4 filings, Elmelech Idan is listed as COO & Principal Financial Ofcr of BridgeBio Oncology Therapeutics, Inc. (BBOT). Elmelech Idan reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 5.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BBOTBridgeBio Oncology Therapeutics, Inc. | COO & Principal Financial Ofcr | 1 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-05
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.